Clinical Trial Update: Study of Pemetrexed in Mesothelioma and Lung Cancer Patients With Fluid Around the Lungs or Abdomen [Phase 2]

View source ↗

Summary

Phase 2 study of pemetrexed in non-small cell lung cancer and mesothelioma, including patients with pleural effusion or ascites, with results posted in 2010.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Mesothelioma
• Non-small Cell Lung Cancer

Drugs mentioned

• Alimta (pemetrexed)

Snippet

Sponsor: Eli Lilly and Company | Conditions: Non-small Cell Lung Cancer, Mesothelioma | Phase 2 | Status: COMPLETED | Results posted: 2010-07-09